IPG Photonics Corp.: Q2 FY2026 earnings call

What management said about Q2 FY2026, from the documents filed with the SEC on 4 August 2026: press release. Guidance figures: 4 raised, 1 kept. The quarter’s numbers.

Read the filing

Key takeaways

• Revenue rose 11 percent: Second-quarter revenue was $278.6 million, up from $250.7 million. Foreign exchange added about 2 percent to the growth rate. Source
• Adjusted EBITDA and EPS both rose: Adjusted EBITDA was $48.5 million against $31.5 million a year earlier. Adjusted diluted EPS was $0.58 against $0.30. Source
• Industrial Solutions grew 16 percent: Industrial Solutions sales were $237.0 million, up 16 percent and 85 percent of revenue. Growth came from welding, marking, cleaning and additive manufacturing. Source
• Advanced Solutions sales fell 9 percent: Advanced Solutions sales were $41.5 million, down 9 percent, on lower micromachining and defense sales, partly offset by semiconductor sales. Source
• Adjusted gross margin rose to 40.7%: Adjusted gross margin was 40.7 percent against 37.8 percent. Management attributed the rise to lower product costs, lower inventory provisions and $4.7 million of tariff refunds. Source
• Lumibird Medical acquisition announced: Management said the recently announced acquisition of Lumibird Medical will further expand its medical-market presence within Advanced Solutions. Source
• Impairment charge of $17.6 million: GAAP operating expenses include a $17.6 million impairment charge in the second quarter. The document does not name the impaired asset. Source

“We delivered our third consecutive quarter of double-digit year-over-year revenue growth, with revenue above the midpoint of our guidance and adjusted gross margin and adjusted EPS above our expectations,”

Dr. Mark Gitin, Chief Executive Officer of IPG Photonics

Guidance

What changed from last quarter

• Guidance raised: Third-quarter revenue range raised to $265 million to $295 million from $260 million to $290 million. Source
• Guidance raised: Adjusted gross margin range raised to 37.5% to 40.5% from 37% to 40%. Source
• Guidance raised: Adjusted diluted EPS range raised to $0.30 to $0.60 from $0.25 to $0.55. Source
• Guidance raised: Adjusted EBITDA range raised to $35 million to $51 million from $32 million to $48 million. Source
• Guidance kept: Adjusted operating expense range of $92 million to $95 million is the same as the prior guidance. Source
• New: Company announced an acquisition of Lumibird Medical, which the prior release did not mention. Source

Results and growth drivers

• Revenue rose 11 percent: Second-quarter revenue was $278.6 million, up from $250.7 million. Foreign exchange added about 2 percent to the growth rate. Source
• Adjusted EBITDA and EPS both rose: Adjusted EBITDA was $48.5 million against $31.5 million a year earlier. Adjusted diluted EPS was $0.58 against $0.30. Source
• GAAP net income declined: GAAP net income was $5.2 million, down 21 percent, and diluted EPS was $0.12 against $0.16. Six-month net income was $6.8 million against $10.4 million. Source
• Operating result swung to a six-month loss: Second-quarter operating income was $4.5 million. The six-month GAAP operating result was a $3.2 million loss, against $1.9 million of operating income a year earlier. Source

Segments and regions

• Industrial Solutions grew 16 percent: Industrial Solutions sales were $237.0 million, up 16 percent and 85 percent of revenue. Growth came from welding, marking, cleaning and additive manufacturing. Source
• Advanced Solutions sales fell 9 percent: Advanced Solutions sales were $41.5 million, down 9 percent, on lower micromachining and defense sales, partly offset by semiconductor sales. Source
• Asia grew while North America slipped: Year over year, sales rose 19 percent in Asia and 5 percent in Europe, and fell 2 percent in North America. Source

“Our book-to-bill remained above one in the second quarter, pointing to ongoing robust demand for our solutions and the team's focused execution of our growth strategy,”

Dr. Mark Gitin, Chief Executive Officer of IPG Photonics

Demand, products and customers

• Industrial demand cited as improving: The release headline credits the quarter's results to improving industrial demand and continued focus on strategic initiatives. Source
• Battery manufacturing cited in Industrial: Management said Industrial Solutions growth reflected demand and execution across markets and applications, particularly battery manufacturing. Source
• Emerging growth share rose to 58%: Emerging growth products were 58 percent of total revenue, up from 53 percent in the prior quarter. Source
• CROSSBOW interest continues: Management said it continues to see interest in its CROSSBOW directed energy system. No figures were given. Source

Margins and costs

• Adjusted gross margin rose to 40.7%: Adjusted gross margin was 40.7 percent against 37.8 percent. Management attributed the rise to lower product costs, lower inventory provisions and $4.7 million of tariff refunds. Source
• Adjusted operating income rose: Adjusted operating income was $23.9 million against $6.9 million a year earlier, per the non-GAAP reconciliation. Source
• Operating expense lines moved mixed ways: Sales and marketing fell to $23.8 million from $25.6 million. R&D rose to $31.0 million from $29.9 million, and G&A rose to $36.5 million from $34.9 million. Source

“Advanced Solutions revenue benefited from our continued focus on key strategic initiatives,”

Dr. Mark Gitin, Chief Executive Officer of IPG Photonics

Cash, capital and returns

• Quarter cash flow and capital spending: Second-quarter cash flow from operations was $37.8 million and capital expenditures were $20.7 million. Source
• Six-month operating cash flow rose: Six-month net cash from operating activities was $32.3 million, up from $11.2 million a year earlier. Source
• No share repurchases in first half: The company bought no treasury stock in the first half of 2026, against $30.2 million in the first half of 2025. Source
• Cash and short-term investments reported: At June 30, 2026, cash and cash equivalents were $399.2 million and short-term investments were $472.1 million. Source

Strategy and acquisitions

• Lumibird Medical acquisition announced: Management said the recently announced acquisition of Lumibird Medical will further expand its medical-market presence within Advanced Solutions. Source
• One IPG Operating Model cited: Management credited the One IPG Operating Model and an innovation engine with unlocking additional and lasting value for customers and stockholders. Source
• Technology leadership cited for laser adoption: Management cited its technological leadership in lasers and photonics, and its record of solving customer problems, as continuing to support laser adoption. Source

Charges, litigation and tax

• Impairment charge of $17.6 million: GAAP operating expenses include a $17.6 million impairment charge in the second quarter. The document does not name the impaired asset. Source
• Litigation settlement and fees: Settlement and fees of litigation matters were $0.3 million in the second quarter and $14.4 million for the six months, per the non-GAAP reconciliation. Source
• Non-GAAP tax provision set at 29%: The GAAP tax rate was 58 percent against 20 percent a year earlier. The non-GAAP tax provision for the quarter was 29 percent. Source

Coming up, as management said on 4 August 2026

• Third-quarter 2026 guidance: Management gave third-quarter ranges for revenue, adjusted gross margin and adjusted operating expenses. The next guidance update is not dated in the release. Source
• Lumibird Medical acquisition pending: Management said the Lumibird Medical acquisition will further accelerate its expansion into medical markets. No closing date is stated. Source

Figures management reported

Earlier plans management reported on

• Ahead: Management said second-quarter revenue was above the midpoint of prior guidance, and adjusted gross margin and adjusted EPS were above its expectations. Source

Other quarters

• Q1 FY2026 earnings call
• Q4 FY2025 earnings call
• Q3 FY2025 earnings call
• Q2 FY2025 results

Summarised with AI from the documents the company filed with the SEC. Every point is checked against the filing before it is shown: management’s own words word for word, figures against the line or table row they come from. A point that fails the check is left out. Source opens the filing at that line.